Shares of Health Care sector company Illumina moved -0.2% today, and are now trading at a price of $207.67. The large-cap stock's daily volume was 46,722 compared to its average volume of 1,242,701. The S&P 500 index returned a 1.0% performance.
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is based in San Diego and has 11,500 full time employees. Its market capitalization is $32,832,626,688.
19 analysts are following Illumina and have set target prices ranging from $150.0 to $336.0 per share. On average, they have given the company a rating of hold. At today's prices, ILMN is trading -13.08% away from its average analyst target price of $238.92 per share.
Over the last year, ILMN's share price has increased by 9.9%, which represents a difference of -6.0% when compared to the S&P 500. The stock's 52 week high is $248.87 per share whereas its 52 week low is $173.45. Illumina's average free cash flow over the last 4 years has been $767.0 Million, but they have been decreasing at an average rate of -21.9%. This may prove a challenge to the long term sustainability of the stock's upwards trend.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-31 | 392,000 | -466,000 | 392,000 | -28.07 |
| 2021-12-31 | 545,000 | -208,000 | 545,000 | -49.54 |
| 2020-12-31 | 1,080,000 | -189,000 | 1,080,000 | 2.76 |
| 2019-12-31 | 1,051,000 | -209,000 | 1,051,000 | n/a |
